The world’s first intranasal vaccine for Covid-19, iNcovacc was launched by Bharat Biotech. The vaccine, priced at ₹800 for private markets and ₹325 for supplies to the Union and State Governments, was formally launched by Union Ministers Mansukh Mandaviya and Jitendra Singh on Republic Day in New Delhi.
How was the technology developed? What is the vaccine’s efficacy? Is it as potent as the vaccines administered through injection? Here’s all you need to know about it.
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.